- Home
- MNY vs CELU Comparison
MNY vs CELU Comparison
Compare MNY & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- CELU
- Stock Information
- Founded
- MNY 2014
- CELU 2016
- Country
- MNY Singapore
- CELU United States
- Employees
- MNY N/A
- CELU N/A
- Industry
- MNY
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- CELU Health Care
- Exchange
- MNY Nasdaq
- CELU Nasdaq
- Market Cap
- MNY 40.6M
- CELU 42.2M
- IPO Year
- MNY N/A
- CELU N/A
- Fundamental
- Price
- MNY $0.79
- CELU $1.77
- Analyst Decision
- MNY
- CELU
- Analyst Count
- MNY 0
- CELU 0
- Target Price
- MNY N/A
- CELU N/A
- AVG Volume (30 Days)
- MNY 42.6K
- CELU 175.7K
- Earning Date
- MNY 04-28-2025
- CELU 12-06-2024
- Dividend Yield
- MNY N/A
- CELU N/A
- EPS Growth
- MNY N/A
- CELU N/A
- EPS
- MNY N/A
- CELU N/A
- Revenue
- MNY $90,185,081.00
- CELU $48,200,000.00
- Revenue This Year
- MNY $18.50
- CELU N/A
- Revenue Next Year
- MNY $24.83
- CELU $233.89
- P/E Ratio
- MNY N/A
- CELU N/A
- Revenue Growth
- MNY 24.60
- CELU 225.94
- 52 Week Low
- MNY $0.65
- CELU $1.00
- 52 Week High
- MNY $2.75
- CELU $5.69
- Technical
- Relative Strength Index (RSI)
- MNY 42.53
- CELU 51.89
- Support Level
- MNY $0.65
- CELU $1.47
- Resistance Level
- MNY $0.82
- CELU $2.40
- Average True Range (ATR)
- MNY 0.06
- CELU 0.21
- MACD
- MNY 0.01
- CELU 0.06
- Stochastic Oscillator
- MNY 72.68
- CELU 45.48
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.